Search again:
…action. Evidence & Policy: A Journal of Research, Debate and Practice, 13(3) 539-560 doi: https://doi.org/10.1332/174426416X14712553750311 [2] Hanney S, Kuruvilla S, Soper B, Mays N. Who needs what from a national…
…will be informed by SRAC’s research framework. Finally in the “now,” we’re listening to you: our awardees and supervisors, applicants, peer reviewers, research administrators and partners, who are raising important…
…that cause prostate cancer to progress, and have developed targeted drugs that are currently being tested in clinical trials. Leader: Martin Gleave, MD, FRCSC, FACS University of British Columbia/Vancouver General…
…is the largest killer of young people worldwide. Conversely, undesired clotting, or thrombosis, is a leading killer of Canadians because it causes strokes and heart attacks. New drugs have led…
…students, parents, and teachers, produced for the Centre for Health Evaluation and Outcome Sciences (CHÉOS) Work in Progress Seminar Series, featuring Anne Gadermann, Kimberly Thomson, and Monique Gagné Petteni. …
Parkinson’s disease (PD) is a neurodegenerative disorder that affects millions of people worldwide, with no standard treatment currently available. Therefore, there is a major need for new therapeutic agents to…
…S., MacIntosh, H., Chamberland, L., MacDonnell, J., Daley, A., Churchill, M. (2018). Supporting Lesbian, Gay, Bisexual, & Transgender Inclusivity in Long-Term Care Homes: A Canadian Perspective. Canadian Journal on Aging…
…contact lenses, artificial hips, dental materials, stents, and are involved in drug delivery systems and blood storage bags. While biomaterials based on synthetic polymers are extremely versatile, they also come…
Health Canada has posted an update (version 2) of their Clinical Trial Risk Classification Guide known as ‘Health Canada, GUI 0043 – Risk Classification Guide for Observations related to Inspections…